Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
congress
3
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
3
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
bristol-myers squibb
celgene
drug prices
pbms
pharmacy benefit managers
president trump
pricing
2019
abbvie
activism
acute hepatic porphyria
What
bio
drug
executives
pharma
roundup
advanced
alnylam’s
approval
away
bff
biopharma
bringing
ceos
conference
congress
congressional
crispr
dc
deals
devoted
disease
easl
feud
form
gathered
gene
group
groups
hearing
held
isn’t
kicked
known
later
liver
lower
major
month
new
ny
Language
Current search:
congress
×
sanofi
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More